Vascular endothelial growth factor: a neurovascular target in neurological diseases
C Lange, E Storkebaum, CR De Almodóvar… - Nature Reviews …, 2016 - nature.com
Brain function critically relies on blood vessels to supply oxygen and nutrients, to establish a
barrier for neurotoxic substances, and to clear waste products. The archetypal vascular …
barrier for neurotoxic substances, and to clear waste products. The archetypal vascular …
The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia
C Iadecola - Acta neuropathologica, 2010 - Springer
There is increasing evidence that cerebrovascular dysfunction plays a role not only in
vascular causes of cognitive impairment but also in Alzheimer's disease (AD). Vascular risk …
vascular causes of cognitive impairment but also in Alzheimer's disease (AD). Vascular risk …
Vascular dysfunction in Alzheimer's disease: a prelude to the pathological process or a consequence of it?
K Govindpani, LG McNamara, NR Smith… - Journal of clinical …, 2019 - mdpi.com
Alzheimer's disease (AD) is the most prevalent form of dementia. Despite decades of
research following several theoretical and clinical lines, all existing treatments for the …
research following several theoretical and clinical lines, all existing treatments for the …
Differing associations between Aβ accumulation, hypoperfusion, blood–brain barrier dysfunction and loss of PDGFRB pericyte marker in the precuneus and parietal …
Recent studies implicate loss of pericytes in hypoperfusion and blood–brain barrier (BBB)
leakage in Alzheimer's disease (AD). In this study, we have measured levels of the pericyte …
leakage in Alzheimer's disease (AD). In this study, we have measured levels of the pericyte …
From neurodevelopmental to neurodegenerative disorders: the vascular continuum
J Ouellette, B Lacoste - Frontiers in Aging Neuroscience, 2021 - frontiersin.org
Structural and functional integrity of the cerebral vasculature ensures proper brain
development and function, as well as healthy aging. The inability of the brain to store energy …
development and function, as well as healthy aging. The inability of the brain to store energy …
[HTML][HTML] Evidence of endothelial dysfunction in the development of Alzheimer's disease: is Alzheimer'sa vascular disorder?
RJ Kelleher, RL Soiza - American journal of cardiovascular disease, 2013 - ncbi.nlm.nih.gov
The etiology of Alzheimer's disease (AD) remains unclear. The emerging view is that
cerebrovascular dysfunction is a feature not only of cerebrovascular diseases, such as …
cerebrovascular dysfunction is a feature not only of cerebrovascular diseases, such as …
Post-mortem assessment of hypoperfusion of cerebral cortex in Alzheimer's disease and vascular dementia
Perfusion is reduced in the cerebral neocortex in Alzheimer's disease. We have explored
some of the mechanisms, by measurement of perfusion-sensitive and disease-related …
some of the mechanisms, by measurement of perfusion-sensitive and disease-related …
The neurovascular link in health and disease: molecular mechanisms and therapeutic implications
At first sight, the nervous and vascular systems seem to share little in common. However,
neural and vascular cells not only are anatomically closely tied to each other, but they also …
neural and vascular cells not only are anatomically closely tied to each other, but they also …
The relationship between amyloid-beta and brain capillary endothelial cells in Alzheimer's disease
YL Zhang, J Wang, ZN Zhang, Q Su… - Neural regeneration …, 2022 - journals.lww.com
Neurovascular dysfunction, as an integral part of Alzheimer's disease, may have an
important influence on the onset and progression of chronic neurodegenerative processes …
important influence on the onset and progression of chronic neurodegenerative processes …
Multiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer's disease diagnosis and prognosis
R Craig-Schapiro, M Kuhn, C **ong, EH Pickering… - PloS one, 2011 - journals.plos.org
Background Clinicopathological studies suggest that Alzheimer's disease (AD) pathology
begins∼ 10–15 years before the resulting cognitive impairment draws medical attention …
begins∼ 10–15 years before the resulting cognitive impairment draws medical attention …